Shinpoong Pharmaceutical Co.,Ltd
019175.KSFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
166
Cost of Revenue
104
Gross Profit
61
Gross Margin
37.0%
Operating Income
-15
Operating Margin
-9.3%
Net Income
-12
Net Margin
-7.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-0
EBITDA Margin
-0.0%
2023
12/31/2023
Revenue
150
Cost of Revenue
90
Gross Profit
60
Gross Margin
40.1%
Operating Income
-36
Operating Margin
-23.7%
Net Income
-43
Net Margin
-28.6%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-30
EBITDA Margin
-19.9%
2022
12/31/2022
Revenue
157
Cost of Revenue
98
Gross Profit
58
Gross Margin
37.3%
Operating Income
-26
Operating Margin
-16.3%
Net Income
-26
Net Margin
-16.9%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-16
EBITDA Margin
-10.5%
2021
12/31/2021
Revenue
142
Cost of Revenue
84
Gross Profit
58
Gross Margin
40.9%
Operating Income
-7
Operating Margin
-4.8%
Net Income
-9
Net Margin
-6.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
1
EBITDA Margin
0.7%
2020
12/31/2020
Revenue
148
Cost of Revenue
91
Gross Profit
57
Gross Margin
38.7%
Operating Income
9
Operating Margin
5.7%
Net Income
4
Net Margin
2.5%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
16
EBITDA Margin
10.6%